Lindbrook Capital, LLC Axcella Health Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Axcella Health Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 80 shares of AXLA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 80 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$0.11 - $15.0 $211 - $28,800	-1,920 Reduced 96.0%	80 $0
Q3 2022 Nov 10, 2022	SELL	$1.62 - $2.73 $1,620 - $2,730	-1,000 Reduced 33.33%	2,000 $3,000
Q1 2022 Apr 21, 2022	SELL	$1.58 - $2.82 $13,430 - $23,970	-8,500 Reduced 73.91%	3,000 $8,000
Q4 2021 Jan 18, 2022	BUY	$2.06 - $3.61 $23,690 - $41,515	11,500 New	11,500 $24,000

Others Institutions Holding AXLA

# of Institutions

Shares Held

61.6K

Call Options Held

Put Options Held

Pinnacle Private Wealth, LLC

61.5K
Shares

$0
0.05% of portfolio

View Full List

About Axcella Health Inc.

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

More about AXLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Axcella Health Inc. Transaction History